| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.29 | 0.03 |